| Code | Name | Deposits | Targets | Ligand Type |
|---|---|---|---|---|
| 15P | 2 | 1 | crystallization | |
| MLA | 2 | 2 | biological | |
| MAL | maltose | 2 | 2 | biological |
| 6JZ | 3,6,9,12,15-pentaoxaheptadecane | 2 | 2 | other |
| CXS | 3-cyclohexyl-1-propylsulfonic acid | 2 | 2 | crystallization |
| LY0 | 2 | 2 | crystallization | |
| AMP | 2 | 2 | crystallization | |
| LIG | 3-pyridin-4-yl-2,4-dihydro-indeno[1,2-.c.]pyrazole | 2 | 2 | crystallization |
| LLL | 2 | 2 | biological | |
| L30 | unknown | 2 | 1 | biological |
| AKG | 2-oxyglutaric acid | 2 | 2 | biological |
| CSO | S-HYDROXYCYSTEINE | 2 | 2 | crystallization |
| CSO | S-HYDROXYCYSTEINE | 2 | 2 | biological |
| AE3 | 2-(2-ethoxyethoxy)ethanol | 2 | 2 | other |
| LMR | (2s)-2-hydroxybutanedioic acid | 2 | 1 | other |
| PG4 | 2 | 2 | biological | |
| JWX | unknown | 2 | 1 | biological |
| CSD | 1 | 1 | modified residue | |
| CSA | 1 | 1 | modified residue | |
| ADP | 1 | 1 | crystallization |